The Kuomintang questioned the press release of the Ministry of Health and Welfare of the Ministry of Health and Welfare to remove the press release that responded to the controversy of the vaccine. The Taiwan Epidemic Prevention Command Center responded that the press release was not withdrawn, but it was only transferred to different columns.
Comprehensive Taiwan Liberty Times jointly reported that the campaign office of Jiang Wanan, the mayor of the Kuomintang Taipei Mayor Jiang Wanan, held a press conference on Friday (November 11).The second phase of the coronary vaccine developed by the high -end company commissioned Lu Ziqiu to Esse, and the high -end press release was clarified earlier, but it was pressed by the Ministry of Health and Welfare to withdraw from the press release.
The spokesman questioned whether "the content was revealed too much, so that the Ministry of Health and Welfare was put on a high -end press release", and criticized "Guoan turned around when it encounters high -end", requiring the former Minister of Health and Welfare Chen Shizhong to be Chen ShizhongAnd the current minister Xue Ruiyuan explained clearly.
Wang Bisheng, commander of the Taiwan Central Popular Epidemic Command Center, responded at a press conference of the epidemic in the afternoon that he did not know what he had removed from the shelves, and he was not sure what was removed, but it could be determined.Yes, the Command Center has not contacted or discussed with high -end or discuss any affairs at all, and "it will not stare at the high -end every day like Jiang Wanan's team, and I don't know what the high -end situation they are staring at each other."
Zhuang Renxiang, a spokesman for the command center, said that the press release of Qiu Yisi about High -end companies is currently under the column of "clarification".
According to the Lianhe Morning Post on Saturday (November 12), the relevant press releases issued by the high -end October 25 can still be found under the "clarification instructions" column of the high -end official website.
High -end has previously accused of entrusting Luzhi Company Qiu Yisi Biomedical Company to conduct a second -stage test for high -end vaccines, causing huge controversy, and also affected the Democratic Progressive Party's election in Taipei.
A press release was released on the 25th of the High -end on the 25th, saying that the implementation of clinical trials has a certain rigorous procedure, and follows the standard of the ICH GCP's excellent clinical trial specifications (Guideline for Good Clinical Practice) to ensureThe credibility of the subject's rights and clinical trial data.
The press release also stated that Qiu Yisi Biotech (former name Chio Pharma) is one of the CRO research institutions of Taiwan's excellent CRO trustee.The Moon Clinipace was a strategic merger with Shanghai's Pulse Company, and it was renamed Kangya in October 2022.In November 2020, the second phase of clinical trials of the high -end vaccine planned vaccine, after evaluating several CROs, signed a contract with the American businessman CLINIPACE (Qiu Yisi), entrusted Qiu to conduct a summary and analysis of the data database with thinking.Executive team is performed, and the project has complete independence.
